You are on page 1of 39

Table of Contents Hammar Reliance Documents Updated 11/2011

Core Reliance Documents: .......................................................................................................... 3 Books: .................................................................................................................................... 3 Tumorigenesis/Target organs: ................................................................................................. 3 Concentration: ........................................................................................................................ 3 Fiber burden: .......................................................................................................................... 3 Attribution: ............................................................................................................................. 3 Low level exposure: ................................................................................................................ 4 PEL: ....................................................................................................................................... 4 No Safe Level: ........................................................................................................................ 4 Background: ........................................................................................................................... 5 Genetic alterations: ................................................................................................................. 5 Genetic susceptibility: ............................................................................................................. 5 Alpha by author: ......................................................................................................................... 6 Cullen: .................................................................................................................................... 6 Dodson (top cited): ................................................................................................................. 6 Egilman: ................................................................................................................................. 7 Hammar affidavits and/or declarations: ................................................................................... 7 Hammar books:....................................................................................................................... 8 Heller: ................................................................................................................................... 10 Henderson:............................................................................................................................ 11 Hillerdal:............................................................................................................................... 11 Hodgson and Darnton: .......................................................................................................... 11 Iwatsubo: .............................................................................................................................. 11 Langer and Nolan: ................................................................................................................ 12 Lemen:.................................................................................................................................. 12 Nicholson: ............................................................................................................................ 12 Reid and de Klerk: ................................................................................................................ 12 Rödelsperger: ........................................................................................................................ 13 Rolland: ................................................................................................................................ 13 Selikoff: ................................................................................................................................ 13 Suzuki:.................................................................................................................................. 13 Welch: .................................................................................................................................. 13 American Thoracic Society (ATS): ........................................................................................... 14 Helsinki: ................................................................................................................................... 14 IARC: ....................................................................................................................................... 14 IMIG Consensus Statement ....................................................................................................... 14 WHO (World Health Organization): ......................................................................................... 14 Historical: ................................................................................................................................. 14 Lung cancer, asbestosis, and pleural plaques: ............................................................................ 15 Regions: ................................................................................................................................... 16 Registers: .................................................................................................................................. 16 Calidria/UICC B asbestos: ........................................................................................................ 17 Chrysotile: ................................................................................................................................ 18 Occupations/Trades Associated with Asbestos Exposure: ......................................................... 20 General: ................................................................................................................................ 20 Construction: Carpenters/Electricians.................................................................................... 20 Page 1 of 39

Insulation workers:................................................................................................................ 20 Maintenance workers: ........................................................................................................... 21 Plumbers and Pipefitters ....................................................................................................... 21 Schools/Teachers .................................................................................................................. 21 Textile workers: .................................................................................................................... 22 Products Associated with Asbestos Exposure:........................................................................... 22 Cement pipe: ......................................................................................................................... 22 Drywall, taping and joint compounds: ................................................................................... 23 Floor tiles:............................................................................................................................. 24 Friction products/Brakes: ...................................................................................................... 24 Gaskets: ................................................................................................................................ 24 Kent cigarettes: ..................................................................................................................... 25 Longshoremen/Dockworkers/Shipbuilding Industry/Shipyard Workers................................. 25 Pulp and Paper Mills ............................................................................................................. 25 RT Vanderbilt Talc ............................................................................................................... 26 Environmental exposure to asbestos and EPA: .......................................................................... 27 Familial, Household and Non-occupational Exposure: .............................................................. 28 Low-dose exposure: .................................................................................................................. 28 Mesothelioma Types: ................................................................................................................ 29 Deciduoid mesothelioma: ...................................................................................................... 29 Localized malignant mesothelioma: ...................................................................................... 31 Metastatic mesothelioma - unusual locations ......................................................................... 31 Peritoneal mesothelioma: ...................................................................................................... 32 Pseudomesotheliomatous Adenocarcinoma: .......................................................................... 35 Mesothelioma of the tunica vaginalis testis: .......................................................................... 36 Well-differentiated papillary mesothelioma: .......................................................................... 37 Asbestos: Selected Cancers ....................................................................................................... 37 Translocation: ........................................................................................................................... 38 Animal Studies: ........................................................................................................................ 38 Black spots in pleura: ................................................................................................................ 38 SV40 virus: ............................................................................................................................... 38 Radiation-induced mesothelioma: ............................................................................................. 39

Page 2 of 39

Core Reliance Documents:
Books:
1. Dodson RF, Hammar SP, eds. Asbestos: Risk Assessment, Epidemiology, and Health Effects, 2nd ed. Boca Raton: CRC Press/Taylor & Francis Group, 2011. Note: 1st edition published in 2006. 2. Hammar SP, Dodson RF. Chapter 27: Asbestos. In: Tomashefski JF Jr., ed. Dail and Hammar s Pulmonary Pathology, 3rd Edition. New York: Springer, 2008. 3. Hammar SP, Henderson DW, Klebe S, Dodson RF. Chapter 43: Neoplasms of the pleura. In: Tomashefski JF Jr., ed. Dail and Hammar s Pulmonary Pathology, 3rd Edition. New York: Springer, 2008. 4. Galateau-Sallé F, ed. International Mesothelioma Panel: Brambilla E, Cagle PT, Churg AM, et al. Pathology of malignant mesothelioma. London: Springer, 2006. 5. Henderson DW, de Klerk NH, Hammar SP, et al. Asbestos and lung cancer: is it attributable to asbestosis or to asbestos fiber burden? In: Corrin B, ed. Pathology of Lung Tumors. Churchill Livingstone, 1997:83-118.

Tumorigenesis/Target organs:
· Weinberg RA. Chapter 11, Multistep Tumorigenesis. In: The Biology of Cancer. Garland Science, Taylor & Francis Group LLC, New York 2007:399-462.

Concentration:
· Dodson RF, O Sullivan M, Corn CJ, McLarty JW, Hammar SP. Analysis of asbestos fiber burden in lung tissue from mesothelioma patients. Ultrastruct Pathol 1997;21:321-336.

Fiber burden:
1. Kohyama N, Suzuki Y. Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of North American Insulation Workers. Ann NY Acad Sci 1991;643:27-52. 2. Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Ind Health 2001;39:150-160. 3. Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann N Y Acad Sci 2002;982:160-176. 4. Suzuki Y, Yuen SR, Ashley R. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health 2005;208:201-210. 5. Dodson RF, et al. Asbestos fiber length as related to potential pathogenicity: a critical review. Am J Ind Med 2003;44:291-297. 6. Dodson RF. Analysis and relevance of asbestos burden in tissue. In: Asbestos: Risk assessment, epidemiology, and health effects, 2nd ed. Dodson RF, Hammar SP (Eds). CRC Press/Taylor Francis 2011:49-108.

Attribution:
1. World Health Organization. Environmental Health Criteria 203. Evaluation of health risks

Page 3 of 39

Rolland P. NIOSH. Occup Environ Med 199.of exposure to chrysotile asbestos. 3. OSHA. there is no implication that such a level is safe. Gramond C. Jöckel KH.1 f/cc level leaves a remaining significant risk. Low level exposure: 1. The quantitative risk of mesothelioma and lung cancer in relation to asbestos exposure. Table 6 on page 22644. Occup Environ Med 2009. et al. 1980 (page 3): All levels of asbestos exposure studied to date have demonstrated asbestos related disease there is no level of exposure below which clinical effects do not occur.137-144. Hodgson JT. Evaluation of all available human data provides no evidence for a threshold or a safe level of asbestos exposure. 4. et al. Ann Occup Hyg 2000. Ducamp S. Darnton A. Am J Epidem 1998. 5. pages 22612-22790. The 0. Darnton A. even if it cannot be easily or precisely measured. Lung Cancer 2006. Risk of pleural mesothelioma: A French population-based case-control study (1998-2002). Hillerdal G. Iwatsubo Y. Occupational Safety and Health Administration. NIOSH. Consensus Report. but not eliminate. 1986 (page 319): a linear. 1980: It is important to point out that when a permissible level for exposure (PEL) to a certain carcinogen is set by OSHA. Mesothelioma risk from chrysotile. Table 11. 2. 3.44:565-601. tremolite. Hodgson JT. 1994 (page 40978): reducing exposure to 0. No Safe Level: 1. 2. anthophyllite & actinolite. Geneva: 1998. Asbestos. To the contrary. Final Rules. Pairon JC. it is the agency s policy that any occupational exposure to a carcinogen carries with it some risk of disease. 1976 (page 92): excessive cancer risks have been demonstrated at all fiber concentrations studied to date. Part II: Depart of Labor. 5. Mesothelioma: cases associated with non-occupational and low dose exposures.148:133-142. asbestosis and cancer: The Helsinki criteria for diagnosis and attribution. Page 4 of 39 .39:262-275. Am J Ind Med 2001. specifically.1 f/cc would further reduce. specifically.56:505-513.54:S9(35). page 585. Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study. NIOSH.23:311-316. Pohlabein H. no threshold. Scand J Work Environ Health 1997. significant risk. PEL: · Federal Register 1986. 2. dose-response relationship Any asbestos exposure carries with it some increased risk of asbestos related disease. Boutin C. 29 CFR Parts 1910 and 1926: Occupational exposure to asbestos. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: Results from a German hospital-based case-control study. Rödelsperger K. et al. USPHS. 4. 6.

659:126-136. Pan XL et al. Environmental: 1. chromosomal deletions and tumor suppressor gene alterations in human malignant mesothelioma. Ugolini D. We find therefore that no minimum threshold level of exposure or duration of exposure has been identified with regard to the risk of pathologies associated with chrysotile. Background: · Roggli VL. WTO. Genetic susceptibility: · Neri M. 2004 (Table 2. Page 5 of 39 . Oury TD. which does not identify any minimum exposure threshold. Occup Environ Med 2010. Rey G. Dianzani I. Environmental exposure to asbestos and the exposure-response relationship with mesothelioma.#59. 2. lung cancer and mesothelioma in a dose-dependent manner. et al. Awad Allah HI. Mutat Res 2008. Am J Respir Crit Care Med 2005. 3. Madkour MT. WHO.6. Lung Cancer 2006.172:1019-1025.15:25-38. Luce D. Goldberg S. 2nd Edition. Eastern Mediterranean Health Journal 2009. Pathology of Asbestos-Associated Diseases.2). Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates. Genetic alterations: · Jaurand M-C..67:417-421. et al. Sporn TA. eds. except for asbestosis. Asbestos. 7. et al. The experts also agree that the linear relationship model. is appropriate for assessing the existence of a risk. 1998 (page 144): Exposure to chrysotile asbestos poses increased risks for asbestosis. Springer: New York. No threshold has been identified for carcinogenic risks. El Bokhary MS. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.54 (Supp 1):S15. 2000: the experts confirm the position of the European Communities according to which it has not been possible to identify any threshold below which exposure to chrysotile would have no effect.

4. 14. 7. Analysis of asbestos fiber burden in lung tissue from (55) mesothelioma patients.17:1-6. A comparison of asbestos burden in lung parenchyma. Toxicology and Industrial Health 2001. Predictors of lung cancer among asbestos-exposed men in the betacarotene and Retinol efficacy trial.21:321-336. Am J Ind Med 2003. An assessment of asbestos body formation in extrapulmonary sites: liver and spleen.35:281-286 5. and plaques. Asbestos content of omentum and mesentery in nonoccupationally exposed individuals. and ATEM as illustrated from data generated from a case report. Toxicology and Industrial Health 2001. Inhal Toxicol 2004.53-60. Am J Epidemiol 2005. Mesothelioma in an individual following exposure to crocidolite-containing gaskets as a teenager. Ultrastruct Pathol 2007. Pleural mesothelioma in a woman whose documented past exposure to asbestos was from smoking asbestos-containing filtered cigarettes. Asbestos fiber length as related to potential pathogenicity: a critical review. Am Rev Respir Dis 1990. 2. Ann NY Acad Sci 1991. Dodson RF et al. Dodson. 10. Cullen MR. Inhalation Toxicology 2008. Am J Ind Med 2000. et al. Dodson RF.37:169-174.17:190-194. Poye LW. Asbestos content in the lymph nodes of nonoccupationally exposed individuals. Analysis of miners and millers compensated for asbestos-related diseases since independence (1980). Dodson RF.19:161-169. Chrysotile asbestos and health in Zimbabwe: I. et al. Cullen MR.117:486-493. Williams MG. Inhal Toxicol 2006. Poye LW. Dodson RF et al. Hammar SP.16:637-647. et al. Tissue burden of asbestos in nonoccupationally exposed individuals from East Texas. Dodson RF.161:260-270. Asbestos content in lung tissue. 2. Dodson RF et al. 3.Alpha by author: Cullen: 1. Int J Occup Environ Health 2011. 6. 9.643. Am J Ind Med 1999. Chest 2000. Dodson et al. SEM.17:138-143. Dodson (top cited): 1. Ultrastruct Pathol 1997.142:843-847.31:95-133 13.44:291-297.18:679-684 12. Hammar SP.20:723-732. lymph nodes and pleural plaques from former shipyard workers. Page 6 of 39 . Hammar SP. 11. et al. Asbestos in extrapulmonary sites: omentum and mesentery. Am J Ind Med 1991. Baloyi RS. Quantitative analysis of asbestos burden in a series of individuals with lung cancer and a history of exposure to asbestos. Dodson RF. A technical comparison of evaluating asbestos concentration by PCM. lymph nodes. et al. Characteristics of asbestos concentration in lung as compared to asbestos concentration in various levels of lymph nodes that collect drainage from the lung. Dodson RF et al. Dodson et al. Dodson RF. 8.

Billings MA. Anything but Chrysotile. Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability. 6.15:202-228. 3. 3. asbestos potency. A case of occupational peritoneal mesothelioma from exposure to tremolite-free chrysotile in Quebec. Affidavit re asbestos and joint compounds dated 12-22-10. 5. Affidavit re asbestos and lung cancer dated 12-22-10.Palmore case for Aaron DeLuca.44:540-557. Int J Occup Environ Health 2009. Letters to the Editor. Int J Occup Environ Health 2006. Am J Ind Med 2003. 4. Int J Occup Environ Health 2005. Egilman D et al. Egilman D.Wheeler case for Aaron DeLuca. Letters to the Editor. Affidavit re exposure to asbestos products. Egilman s response re Setting the Record Straight. 7. and environmental causation: a peer review of published work and legal and regulatory scientific testimony. 4. Affidavit re autopsies and fiber burden analysis. 2. Egilman D. Fiber types. Exposing the myth of ABC. Egilman DS. Egilman s response re Controlled Use of Asbestos. Page 7 of 39 . 5. Howe S. Canada: A black swan case. Affidavit re asbestos and mesothelioma dated 12-22-10. 2.11:360-371. Affidavit re exposure to joint compounds. Int J Occup Environ Health 2007. Egilman D.Egilman: 1.13:118-124 6. Am J Occup Env Health 2004. Am J Ind Med 2010. Hammar affidavits and/or declarations: 1. Menendez LM. Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology.

Hammar SP.The Molecular Pathogenesis and Pathology of Malignant Mesothelioma. Cagle PT. pgs 587-599 .Hammar books: Dail and Hammar s Pulmonary Pathology.520 o 25-30 = 1.300 o 40-44 = 6.156 o 35-39 = 493 o 40+ = 1. pgs 581-582 .550 o 30-34 = 2. pg 613 o Histochemical features.Pleural/peritoneal mesothelioma ratios. Tomashefski JF Jr. Hammar SP.Malignant mesothelioma in children. pg 573 . pgs 631-637 o Cytogenetic and molecular features.710 o 31+ = 3. pgs 573-578 . Farver CF.Chrysotile and mesothelioma. pg 613 o Mesotheliomas showing variable differentiation. 3rd edition. pgs 568-570 .700 o 25-29 = 6. pgs 637-639 . pgs 639-661 Mesothelioma rates in groups exposed occupationally to asbestos. pgs 583-584 o Chrysotile content of human lung tissue from mesothelioma patients. pgs 613-615 o Immunohistochemical features. pgs 561-563 . according to fiber types and duration (Table 43.Threshold or minimal level of asbestos exposure.180 Insulation workers · Mixed fiber exposure: mainly amosite · Duration (years since 1st employed) and rate per 106 person-years: o 20-24 = 290 o 25-29 = 1. chrysotile · Duration (years since 1st employed) and rate per 106 person-years: o 20-24 = 1. pg 583 o Other chrysotile-exposed cohorts/studies. Dodson RF.Occupations at risk.774 Insulation manufacture · Amosite Page 8 of 39 . Fraire AE (Ed). Dodson RF.Asbestos fiber types and dose.760 o 35-39 = 6.Pathologic Features of Malignant Pleural Mesothelioma. pgs 612-613 o Pleomorphic mesothelioma. Springer 2008 (2 volume set) · Chapter 27 (volume I) Asbestos.Mineral fibers and mesothelioma. pgs 559-561 . pgs 608-610 o Biphasic malignant mesothelioma. Pages 558-734 .300 o 30-34 = 9.Rare/unusual mesotheliomas or mesothelial proliferations. pgs 585-587 .Latency. Henderson DW.600 Textile manufacture · Chrysotile. pgs 584-585 o Chrysotile only exposure: asbestos and mesothelioma among automotive and brake mechanics. pgs 582-587 o The Quebec chrysotile cohort. pgs 615-631 o Ultrastructural features. pgs 601-608 o Sarcomatoid mesothelioma. pgs 579-581 . Klebe S. pgs 599-639 o Epithelial mesothelioma.Asbestos: Etiology. Pages 950-1031 · Chapter 43 (volume II) Neoplasms of the Pleura.Mesothelioma: Incidence and epidemiology. pgs 611612 o Transitional mesothelioma. amosite. pg 565 .330 o 45+ = 8.8): Industry: Textile manufacture and insulation · Mixed fiber exposure: crocidolite.. pgs 570-571 . some crocidolite · Duration (years since 1st employed) and rate per 106 person-years: o 20-24 = 108 o 25-29 = 143 o 30-34 = 1. and mesothelioma risk and induction.110 Fibrous cement manufacture · Mixed fiber exposure: crocidolite and chrysotile · Duration (years since 1st employed) and rate per 106 person-years: o 20-24 = 2.

pgs 670-672 Solitary fibrous tumors of the pleura. pg 650-652 o Desmoplastic sarcomatoid mesothelioma and its distinction from benign fibrous pleuritis.842 Dockyards · Mixed fiber exposure · Duration (years since 1st employed) and rate per 106 person-years: o 20-24 = 120 o 25-29 = 410 o 30-34 = 220 o 35-40 = 370 o 40-44 = 1. pgs 660-661 Pseudomesotheliomatous tumors of the pleura.- Adenomatoid tumor of the pleura. epidemiology. pgs 657659 o Pleomorphic mesothelioma. pgs 649-650 o Gaucher cell-like mesothelioma. pgs 678-683 o · Asbestos: Risk assessment. pgs 648-649 o Deciduoid mesothelioma. CRC Press/Taylor Francis 2006 o Chapter 1: The history of the Extraction and Uses of Asbestos by Arthur L. pgs 652-657 o Lymphohistiocytoid mesothelioma.510 Mining and milling · Crocidolite · Duration (years since 1st employed) and rate per 106 person-years: o 20-24 = 900 o 25-29 = 2. Hammar SP (eds). epidemiology. pgs 659-660 o Localized malignant mesothelioma.240 o 45-49 = 1. Dodson RF. Dodson o Chapter 4: Molecular and cellular responses to asbestos exposure by Mark A. Millette o Chapter 3: Analysis and relevance of asbestos burden in tissue by Ronald F. pgs 641-642 o Noninvasive atypical mesothelial proliferations. pg 650 o Multicystic mesothelioma. and health effects. 2nd ed. L. Dodson RF. pg 649 o Mucin-positive epithelial mesothelioma. Hammar SP (eds). CRC Press/Taylor Francis Group 2011 o Chapter 1: The history of asbestos utilization and recognition of asbestos-induced disease Duration (years since 1st employed) and rate per 106 person-years: o 20-24 = 744 o 25-29 = 2. Atkinson o Chapter 5: The pathologic features of asbestosinduced disease by Samuel P. Levin and Paul P. Hammar o Chapter 6: Epidemiology of asbestos-related diseases and the knowledge that led to what is known today by Richard A. Lemen o Chapter 7: Clinical diagnosis of asbestos-related disease by Gary K. Friedman o Chapter 8: Core curriculum for practicing physicians by Jeffrey L.078 o 35+ = 1. and health effects.000 Page 9 of 39 . Frank o Chapter 2: Asbestos analysis and methods by James R.623 o 30-34 = 5.000 o 35-39 = 7. Rountree Asbestos: Risk assessment. pgs 640641 o Well-differentiated papillary mesothelioma.200 o 30-34 = 3. pgs 642-648 o Small cell mesothelioma.

DW Henderson. Page 10 of 39 .o o o o o o o o o o o o o o by DW Henderson and J Leigh Chapter 2: Asbestos analysis methods by JR Millette Chapter 3: Analysis and relevance of asbestos burden in tissue by RF Dodson Chapter 4: The molecular pathogenesis of asbestos-related disorders by S Klebe and DW Henderson Chapter 5: Epidemiology of asbestos-related diseases and the knowledge that led to what is known today by RA Lemen Chapter 6: Asbestos and carcinoma of the lung by DW Henderson and J Leigh Chapter 7: Asbestos and mesothelioma by SP Hammar Chapter 8: Asbestos and other cancers by SP Hammar. Gordon RE. Am J Ind Med 1996. Asbestos exposure and ovarian fiber burden. RA Lemen. and J Leigh Chapter 9: Asbestosis by SP Hammar Chapter 10: Asbestos-induced pleural disease by SP Hammar Chapter 11: Uncommon nonmalignant asbestos-induced conditions by SP Hammar Chapter 12: Clinical diagnosis and management of nonmalignant asbestosrelated disorders by GK Friedman Chapter 13: Malignant diseases attributed to asbestos exposure by GK Friedman Chapter 14: Core curriculum for practicing physicians related to asbestos by JL Levin and PP Rountree Chapter 15: Asbestos regulations and their applications by DT Crane and AC Malott Heller: 1. Westhoff C. Gerber S.29:435-439. Heller DS.

Henderson DW. Henderson DW. Note: The authors stated the risk of mesothelioma caused by chrysotile derived from these data was higher by a factor of 10.44:565-601. asbestosis. Ann Occup Hyg 2000.23:93-103. Mesothelioma risk from chrysotile. Pairon JC. Pathology 2004. Treatment and Control. Hillerdal G. 5. Hillerdal G. Darnton A. 2. Iwatsubo Y. 2. Friction products (e. with emphasis on studies published during 1997-2004. 2001. 3. Scan J Work Environ Health 1997. Churchill Linvinstone 1997. Shilkin KB. Asbestos. 4. Occup Environ Med 2009. Hammar SP. pages 300-304. Iwatsubo: 1. Hodgson and Darnton: 1. Henderson DW. Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. et al. Leigh J. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. European communities measures affecting asbestos and asbestos-containing products.36:517-550. Rodelsperger K Woitowitz H-J. Occup Environ Med 1999. Mesothelioma: Cases associated with non-occupational and low dose exposures. Roggli VL.g.Henderson: 1. Leigh J. et al. Is asbestosis an obligate precursor for asbestos-induced lung cancer? Chapter 4. Ultrastructural Pathol 1988. 2. brake linings). 1995. Corrin B (ed). After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer. Am J Epidemiol 1998. et al.97-168. Hodgson JT. WT/DS135/AB/R. Asbestos and lung cancer: is it attributable to asbestosis or to asbestos fiber burden? In: Pathology of Lung Tumors.56:505-513.83-118. Boutin C. Henderson DW. Peters GA. Page 11 of 39 . pleural plaques and lung cancer. The Michie Company. Pleural mesothelioma: Dose-response relation at low levels of asbestos exposure in a French population-based case-control study. Hodgson JT. Henderson DW. Peters BJ (eds). In: Asbestos Health Effects.148:133-142.12:367-384 Hillerdal: 1. WTO March 12. Henderson DW. Darnton A.

Industrial Health 2001. Asbestos: Risk Assessment. Affidavit re joint compounds dated April 26.39:57-64. mixed fiber exposures were associated with more mesotheliomas than single fiber exposures. Lemen RA. 12% of mesothelioma cases and.Langer and Nolan: 1.34:1-11. 4. Nolan RP. Reid and de Klerk: 1. 2nd ed. Monaldi Arch Chest Dis 1998. 12 asbestosis and 3 other cancers. Lemen RA. 5. Insulation workers primarily exposed to amosite. Chrysotile biopersistence in the lungs of persons in the general population and exposed workers. Epidemiology. Wagoner JK. 35 lung cancers.643:74-84. In: Dodson RF. Comparative dose-response relationships of asbestos fiber types: magnitudes and uncertainties. 107 were probably non-occupationally exposed. Nicholson WJ. Lemen RA. if tremolite exposure was associated with chrysotile exposure. Nolan RP. 2. et al. Int J Occup Environ Health 2004. Am J Ind Med 2004. 33 mesos. Lemen RA. Asbestos in the lungs of persons exposed in the USA. Langer AM. Page 12 of 39 . Environ Health Perspect 1980. 55 of 107 cases contained short chrysotile fibers Lemen: 1. 2006. Chrysotile only exposure was associated with approx. Hammar SP (Eds.45:229237.10:233-239. 2. Asbestos in brakes: Exposure and risk of disease. Nicholson: 1. Crocidolite exposure occurred among USA insulators and a large percentage of other workers. Lemen RA. 3. The carcinogenicity of chrysotile asbestos-A review. Langer AM. Dement JM. The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Reid A. the chrysotile amount exceeded that for tremolite 2. de Klerk N. Chrysotile asbestos as a cause of mesothelioma: application of the Hill causation mode. and Health Effects.102:235-239. Epidemiology of asbestos-related diseases.). · Lung burden analysis performed on 126 autopsy cases between 1966 and 1968.53:168-180. Nicholson WJ. Ann N Y Acad Sci 1991. Occup Environ Med 2005.62:885-889. · 81 workers and 2 household persons. Environ Health Perspect 1994. CRC/Taylor & Francis 2011. Nicholson WJ. Epidemiology of Asbestos-related Diseases and the Knowledge that Led to What is Known Today.

et al. Suzuki Y. Am J Ind Med 1991.39:150-160. Ann NY Academy of Sciences 1991. Ann N Y Acad Sci 2002. Hammond EC. Note: Abstract appeared in Lung Cancer 2006. Kohyama N and Suzuki Y. Rödelsperger K. Page 13 of 39 . Bruckel B. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: Results from a German hospital-based case-control study. Occupations and industries in France at high risk for pleural mesothelioma: A population-based case-control study (1998-2002). Am J Ind Med 1986. and neoplasia.19:701-704. Attributable risk in men in two French casecontrol studies on mesothelioma and asbestos. Asbestos fibers contributing to the induction of human malignant mesothelioma. Welch LS. Eur J Epidemiol 2010. Int J Occup Environ Health 2005. 4. 5. Asbestos exposure causes mesothelioma. Yuen SR.39:262-275. Suzuki: 1. 2. Kohyama N. Churg J. pleural plaques.Rödelsperger: 1.54:S9(35). Short. smoking. Gramond C. Rolland P.11:254-258. Rolland: 1. Jockel K-H. Welch LS. but not this asbestos exposure: An amicus brief to the Michigan Supreme Court. Asbestos exposure. Lacourt A. Rödelsperger K. Suzuki Y. Asbestos tissue burden study on human malignant mesothelioma. Suzuki Y. et al. Translocation of inhaled asbestos fibers from the lung to other tissues. Selikoff: Selikoff IJ. 2. Int J Occup Environ Health 2007. Suzuki Y et al. Asbestos dust exposure during brake repair.13:318327. et al. Am J Ind Med 2001. Asbestos and peritoneal mesothelioma among college-educated men.204:104-110. Welch: 1. et al. Analysis of asbestos fibers in lung parenchyma. Yuen SR.208:201-210. Am J Ind Med 2010. JAMA 1968. and mesothelioma tissues of North American Insulation Workers. Rolland P.643:27-52 3. thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Gramond C. 2. et al. Jahn H. Lacourt A. Ind Health 2001.982:160-176. Pohlabein H. 2. Int J Hyg Environ Health 2005.10:63-72.

Arch Lab Path Med 2009.140:1219-1220. asbestosis and cancer: The Helsinki criteria for diagnosis and attribution. arsenic. Annual report of the Chief Inspector of Factories for the year 1947.American Thoracic Society (ATS): Diagnosis and initial management of nonmalignant diseases related to asbestos. Pathology 2004. 2. Am J Cancer 1935. 8. 1998 Historical: 1. Sleggs CA. dusts. Harris EE.Guidelines for pathologic diagnosis of malignant mesothelioma. Am J Respir Crit Care Med 2004. The occurrence of asbestosis among insulation workers in the United States. Selikoff IJ.191:189-209. Smith WA. Marchand P. Case records of the Massachusetts General Hospital #33111.12:81-86.36:517-550. Wagner JC. WHO document on chrysotile asbestos Environmental Health Criteria 203. Lynch KM. Merewether ERA. Helsinki: 1.com/oncology Volume 10 May 2009 IMIG Consensus Statement . Uber den Lungenkrebs bei Asbestose. Editorial: Asbestosis and cancer of the lung. 4. IARC: IARC Special Report: Policy. 9. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Henderson DW. Hammond EC. Asbestos: from magic to malevolent mineral by Gee D.17:260-271. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer. Anonymous. 5. 6. September 2006. Asbestos. 3. with emphasis on studies published during 1997-2004. A review of human carcinogens-Part C: metals. Mortality from lung cancer in asbestos workers. WHO (World Health Organization): 1.132:139-155. N Eng J Med 1947.24:56-64.thelancet. Dtsch Arch Klin Med 1943. et al.133:1317-1331. 2. WHO Policy Elimination of Asbestos-related diseases. Page 14 of 39 . Greenberg M. Pulmonary asbestosis III: Carcinoma of the lung in asbestosissilicosis. Ann NY Acad Sci 1965.170:691-715. Br J Ind Med 1955. www.236:407-412. JAMA 1949. Mallory TB. Wedler HW. London: His Majesty s Stationery Office 1949:78-81. Br J Ind Med 1960. Scand J Work Environ Health 1997. Castleman B. Doll R. 2. Churg J. and fibres.23:311-316. 7.

5. Banks DE. Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study.134:462-480. 3.83-118. Andrion A. Hammar SP. and pleural plaques: 1. Br J Ind Med 1991. Ann Occup Hyg 2000. de Klerk N.89:20-26. Treatment and Control. Roggli VL. Bellis D. 9. Darnton A. Asbestos.44:565-601. Page 15 of 39 .62:885-889. Leigh J. asbestosis. 10. Isenberg W. Pathology of Asbestosis An update of the diagnostic criteria: Report of the Asbestosis Committee of the College of American Pathologists and Pulmonary Pathology Society. Reid A. Chest 2009. et al. Arch Pathol Lab Med 2010. Is asbestosis an obligate precursor for asbestos-induced lung cancer? In: Asbestos Health Effects.Lung cancer. 6. Peters BJ (Eds). Human Pathology 1989. Attanoos R.The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Gibbs AR. Hillerdal G. Asbestos and lung cancer: is it attributable to asbestosis or to asbestos fiber burden? In: Pathology of Lung Tumors. Corrin B (Ed). 4. et al. Warnock ML. et al.48:229-233. Roggli VL. Hammar SP. et al. Weill H. The Michie Company. 2. asbestosis. Hughes JM. Chest 1986. Occup Environ Med 2005. pleural plaques and lung cancer. 1995.23:93-103 7. Churchill Livinstone 1997. 8. Scand J Work Environ Health 1997. Peters GA. Ambrosini GL.97-168. Shilkin KB. et al. Henderson DW. American College of Chest Physicians Consensus Statement on the Respiratory Effects of Asbestos: Results of a Delphi Study. Minimal pathologic changes of the lung and asbestos exposure.20:102-106.135:1619-1627. Henderson DW. Henderson DW. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Asbestos burden and the pathology of lung cancer. Hodgson JT. de Klerk NH.

56:131-152 10. Musk AB et al. McCulloch J. (www.45:473-477 6. et al.25:749-756. Occupational. Asbestos mining in Southern Africa. Egypt) Registers: 1. Asbestos mining and occupational disease in Southern Rhodesia/Zimbabwe. domestic and environmental mesothelioma risks in the British population: a case-control study. 1915-1998. et al. Am J Ind Med 2002. Final rule. Mesothelioma of the pleura and peritoneum following exposure to asbestos in the London area. et al. 1945-2000. Awad Allah HI. Statement on malignant mesothelioma in the United Kingdom. Baris YI. 1955-1977: Occupational and geographic associations.65(8). Eastern Mediterranean Health Journal 2009. Mirabelli D. British Thoracic Society Statement. 153. et al. Occup Environ Med 2008.bjcancer. et al. Final rule. 2. Volume 73. Malignant mesothelioma in Australia.22:261-269 2. Italy.45:838-840 4. Brit J Industr Med 1988.Regions: 1. Mortality of former crocidolite (blue asbestos) miners and millers at Wittenoom. Br J Cancer 2009. Thompson H. Occupational exposure to asbestos. Asbestos lung fibre concentrations in South African Chrysotile Mine Workers. Environmental exposure to asbestos and the exposure-response relationship with mesothelioma. Australian Mesothelioma Register Report 1999: The incidence of mesothelioma in Australia 1994 to 1996. Case BW et al. Thorax 2001. 3. See page 22644 for Asbestos fiber concentration and cancer mortality (Table 6). Ann Occup Hyg 2001. 13. Newhouse ML. History Workshop Journal 2003.15:25-38. OSHA Final Rules. Page 16 of 39 . Volume 59. 1893-2002. Ann Occup Hyg 2002. El Bokhary MS. (www. No. tremolite. 119.46:144-149 7. Mesothelioma in Connecticut. No.cdc. 4. Federal Register 1994: 29 CFR Parts 1910. (Cairo. An epidemiological study in an Anatolian village environmentally exposed to tremolite asbestos. Excess of mesotheliomas after exposure to chrysotile in Balangero.. 5. McCulloch J.com) 12. J Occup Med 1983. CDC. et al. Asbestos exposure limit. Malignant mesothelioma mortality --. Federal Register 2008: 30 CFR Parts 56.United States. Federal Register 1986: 29 CFR Parts 1910 and 1926. Teta MJ.41:188-201.65:815-819 8. et al. 11.100:1175-1183. Volume 51. Madkour MT. Lung-retained fibre content in Brazilian chrysotile workers. 1995-2005. Rees D. Rake C. Int J Occup Environ Health 2003. No.9:230-235 9. anthophyllite & actinolite. Occup Environ Med 2008.541-543. 41. Brit J Industr Med 1965. 57 and 71.56:250-265. Leigh J et al.gov/mmwr/preview) 14. 3. Occupational exposure to asbestos.

Calidria/UICC B asbestos: (core reliance documents) 1.30:224232. 14. Union Carbide UK Limited.34:314-317. 153. U. Letter and manuscript from Mary S. Sinai School of Medicine dated June 7. Exp Toxicol Pathol 1992. Hatfield RL. Dernehl MD in re Arthur A. Myers JL. Hall from Carl U. Am J Ind Med 1998. Atlas Asbestos Mine Region 9 Superfund. Fusaro from K. 1332-21-4. chemical and biological properties of chrysotile asbestos subjected to prolonged milling.S. Sayers IC. Frank AL. Williams MG. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibers in rats. 7. Selikoff IJ. Yeager H. Environ Research 1983.. 7/11/79. Lane MD dated May 22. Calidria Material Safety Data Sheet C. Turci F. MAS report September 2002. X. Role of associated mineral fibres in chrysotile asbestos health effects: the case of Balangeroite. Wolff MS.44:55-58. Deposition of Carl U. Asbestos as a Health Hazard in the United Kingdom 4. et al. Answers and objections of defendant Union Carbide Corporation to plaintiff s first set of interrogatories. Dernehl dated June 7. Inc. 1967 re Asbestos as a Health Hazard in the United Kingdom 5. Tomatis M. T. 12. Variation of some physical. et al. Yanez M. 1976 concerning prepublication copy of the paper describing work using Calidria HG 144 and prepublication copy of manuscript by Langer AM. Page 17 of 39 . 15. Frehse vs Anchor Packing Co. Study area. Internal correspondence to Mr. Cytotoxicity of a short-fiber chrysotile asbestos for human alveolar macrophages: Preliminary observations. Measurements of Airborne Chrysotile Structure Sizes from Calidria Asbestos. and 155 3. 1309-38-2 (Plaintiff s Exhibit UC2876) 2. pages 1. Fubini B. Wolff of Mt. 5/1/79. Wolff MS.A. Map of Clear Creek Management Area and Atlas Mine Site. Egilman D. Rittinghausen S et al. Revision #2 16. Environmental Protection Agency Region 9 Clear Creek Management Area Asbestos Exposure Risk Assessment Frequently Asked Questions 9. No.S. Robert F. J. Civil Action 76-1901 11. EPA #CAD980496863 8. 17. Dodson RF. In re Norris vs Combustion Engineering. Longo WE. Compagnoni R. The Union Carbide Calidria Asbestos Business. Rohl AN. S.. Letter to the Editor re Controlled Use of Asbestos. Int J Occup Environ Health 2004. Ann Occup Hyg 2009. 13. Russo DA.10:99-103.53:491-497. rev. Carcinogenic implications of the lack of tremolite in UICC reference chrysotile. 10. Letter to Dr. 1973 6.

47:810-814. 6. Carcinogenicity of chrysotile asbestos: a case control study of textile workers. Pooley FD. 17. 23. Yuen SR. et al. Use of asbestos. Evaluation of health risks of exposure to chrysotile asbestos. Ann NY Acad Sci 1979. Ladou J. et al.32:305-313. Asbestos use and carcinogenicity in Germany and a comparison with animal studies. 14. Wang XR. 22.7:59-65.982:160-176.699-705.21:321-336.47:173-178. 20. Westhoff C.44:55-58. The comparative effects of three chrysotiles by injection and inhalation in rats. et al. Dement JM. The carcinogenicity of chrysotile asbestos-a review. Pott F. Dodson RF. The carcinogenicity of chrysotile asbestos. Cullen MR. et al.72:317-324. 19. Wright CC. Chest 2000. 8. Exp Toxicol Pathol 1995.465-472. Exp Tox Pathol 1992. Ind Health 1999. Ann NY Acad Sci 1991. Skidmore JW. Environmental Health Criteria 203. Asbestos fibers contributing to the induction of human malignant mesothelioma. Gordon RE. Am J Ind Med 1996. 10. World Health Organization. Wagner JC. Analysis of asbestos fiber burden in lung tissue from mesothelioma patients. Heller DS. Wang ZM.19:701-704 9. Yuen SR. health risks and induced occupational diseases in the former East Germany. McDonald JC. Suzuki Y. Am J Ind Med 1991. Am J Ind Med 1996. Cell Biol Toxicol 1991.330:1-9. Sturm W. 4. Asbestos-related diseases and asbestos types used in the former GDR. northern Italy. Muhle H.30:252-266. Piolatto G et al. Env Research 1983. Kohyama N.154:538-543. 18. Mohr U. tremolite and carcinogenicity. Cancer mortality among workers exposed to amphibole-free chrysotile asbestos.Chrysotile: (top cited articles in bold) 1. The hazards of chrysotile asbestos: a critical review.363-372 3. 15. Yano E.39:57-64. Glickman et al. Nicholson WJ.38:589-600. Toxicology Letters 1994. Dodson RF. Suzuki Y. 21. 5. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats. Baloyi RS. Rittinghausen S. 2. Nicholson WJ. 7. 12. Ultrastruct Pathol 1997. Chrysotile. Page 18 of 39 . 13. Asbestos in extrapulmonary sites: omentum and mesentery. 11. Liddell FD. Mesothelioma in pet dogs associated with exposure to their owners to asbestos. Translocation of inhaled asbestos fibers from the lung to other tissues. Ann N Y Acad Sci 2002. 1998:137-144. Am J Epidemiol 2001. Ann Occup Hyg 1997. Suzuki Y. Analysis of miners and millers compensated for asbestos-related diseases since independence (1980). Asbestos tissue burden study on human malignant mesothelioma. 16.117:486-493. McDonald AD.29:435-439. Chrysotile asbestos and health in Zimbabwe: I. British J Ind Med 1990. Berry G. Ernest H. Smith AH. Am J Ind Med 1991. McDonald JC. Ind Health 2001. Suzuki Y. Sturm et al. IARC Sci Publ 1980. Ind Health 2001.37:271-280. An update of cancer mortality among chrysotile asbestos miners in Balangero. Ann Occup Hyg 1994. Landrigan PJ. Mortality in Canadian miners and millers exposed to chrysotile. Asbestos exposure and ovarian fiber burden. Chrysotile asbestos is the main cause of pleural mesothelioma.39:150-160. Harington JS.19:161-169. Biological effects of mineral fibers.

10:233-239. Asbestos fiber length as related to potential pathogenicity: a critical review.44:291-297 25. In the District Court. Texas. Follow-up study of chrysotile textile workers: cohort mortality and exposure response. Billings MA. CRC Press/Taylor & Francis Group. Ann Epidemiol 2011. and health effects. et al. See discussion re chrysotile asbestos in Asbestos: Risk assessment. Arch Env Occup Health 2008. Lehman E.64:616-625. 2003. et al. Harris County. 2nd ed.21:688-697. Wolf SH. 33. 29. Am J Ind Med 2003. Short. Case report: Mesothelioma in a worker who spun chrysotile asbestos at home during childhood.66:535-542. Stayner L. Occup Environ Med 2009. Occup Environ Med 2007. Dodson RF.11:360-371 30. Dement JM. 32. May 5. Orally ingested chrysotile asbestos affects rat lungs and pleura. Asbestos. Anything but Chrysotile. Hein MJ. 3rd Edition. 1915-98. Wang Z-M. 36. 35.208:201210. History Workshop Journal 2003:131-152. Hammar SP (eds). Excess of mesotheliomas after exposure to chrysotile in Balangero. Atkinson MAL. Am J Ind Med 2003. Levin JL. Int J Occup Environ Health 2004. Mirabelli D. Chrysotile asbestos as a cause of mesothelioma: application of the Hill causation model. Loomis D. Dement JM. In Re: Asbestos Litigation Brake Hearing. Dodson RF. 2011:196226.65:815-819. Hasanoglu H. Int J Hyg Environ Health 2005. Bayram E. Dodson RF. Occup Environ Med 2008. Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability. Exposing the myth of ABC. Am J Ind Med 2009. Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers. Asbestos mining and occupational disease in Southern Rhodesia/Zimbabwe. Egilman D et al. 11th Judicial District 27. epidemiology. thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence.) New York: Springer 2008 Page 19 of 39 . Yano E. Kanarek MS.24. Suzuki Y et al.44:540-557. Richardson DB. In: Dail and Hammar s Pulmonary Pathology. McCulloch J. Lemen RA. (Eds. 26. et al. 2004-03964. Cause No. Int J Occup Environ Health 2005. Italy. 31.1-6. Egilman DS. Mesothelioma from chrysotile asbestos: update. Tomashefski JF et al. Chapter 27 by Hammar SP. 28.63:71-75. 34.

Occupational Analyses. Lewinsohn HC. J Occup Med 1983. et al. 2nd ed. Analysis of asbestos fibers Page 20 of 39 .45:519-523 2. Table 27-2. Occupational and geographic associations. Lilis R. Penner L. et al. Chapter 27: Asbestos. Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation.Occupations/Trades Associated with Asbestos Exposure: General: 1. Mesothelioma in Connecticut. (Eds. J Occup Environ Med 2003. Estimates of probability of asbestos exposure according to job title. and causes of death. Suzuki Y. Chapter 27: Asbestos. 1955-1977. Ann NY Acad Sci 1991.25:749-756. Asbestos: Risk Assessment.45:1059-1067 List of occupations associated with asbestos exposure. Ann Occup Hyg 2001. Table 27-3. Hammar SP. 1967-1987. Dement J et al. McDonald JC. Tomashefski JR Jr. 3rd Edition. Exposure by trade/job title 5. Case-referent survey of young adults with mesothelioma: II.. Selikoff IJ. Asbestos-associated deaths among insulation workers in the United States and Canada. 952-954 3. Ribak J. Meigs JW. ed. (Eds. Appendix A. Selikoff IJ.) Springer 2008.. 3rd Edition. including but not limited to: Boilermakers Bakers Brake repair and instillation workers Bricklayers and masons Carpenters Cement workers Custodial workers Drywall workers Electricians Engineers Insulators Jewelers Laborers Longshoremen Machinists Maintenance workers Mechanics Merchant Seamen Millwrights Painters Petro-chemical workers Plasterers Plumbers Pipefitters Power Plant workers Railroad workers Roofers Rubber workers Sheet metal workers Shipyard workers Smelter workers School teachers Steel workers Sulfate mill workers Welders Insulation workers: 1. In: Dail & Hammar s Pulmonary Pathology. 6. Chapter 5 by Lemen RA. Tomashefski JR Jr. Seidman H. Roggli VL et al.643:1-14 3. Construction: Carpenters/Electricians 1. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathologic correlation of 1445 cases. British J Ind Med 1988. Ultrastruct Pathol 2002.45:182-187 2. et al. CRC Press/Taylor Francis 2011:170-189. diagnosis. Epidemiology. In: Dodson RF. 2. In: Dail & Hammar s Pulmonary Pathology. and Health Effects. et al. See Findings Specific to Occupations. Kohyama N and Suzuki Y.952-954 4. Cancer incidence among Union carpenters in New Jersey.26:55-65.). Springer 2008. Australian Mesothelioma Register 2002. Estimates of probability of exposure according to industry title. Teta MJ.

Verma DK. Occup Environ Med 2004. 3. Oury TD. Time trends and occupational risk factors for pleural mesothelioma in Sweden. 4. Part I: Monitoring of exposure using personal passive samplers.61:736-742 Schools/Teachers 1. A cohort study of mortality among Ontario pipe trades workers. Health Effects Institute-Asbestos Research 2. Mesothelioma in Connecticut. pleural plaques. Patterns of mortality among plumbers and pipefitters. Asbestos-associated pleural mesothelioma in school teachers: a discussion of four cases. 4.in lung parenchyma.97:325-___ 3.S. Asbestos in Public and Commercial Buildings: a literature review and synthesis of current knowledge. 5. J Occup Med 1983.643:2752. Morgan MS. Ann Occup Hyg 2007. Roggli VL.88:163168. Baldwin CA. Meigs JW. 5. In: Pathology of Asbestos-Associated Diseases. Lilienfeld DE. Ann NY Academy of Sciences 1991. Occupational and geographic associations. Finkelstein MM. 1955-1977. J Occup Environ Med 2003. Mesothelioma among employees with likely contact with in-place asbestos-containing building materials. Darcey DJ. Page 21 of 39 . Bard D. Heid MF. 2nd Ed. et al. et al. Am J Ind Med 1986. 2. Lewinsohn HC. Maintenance workers: Burdett G. Can J Publ Health 1997.45:451-455. Asbestos in Colorado schools.51:121-130 Plumbers and Pipefitters 1. Prevention 1982. et al. Summary statistics for average airborne fiber concentrations in U. Mesothelioma surveillance to locate sources of exposure to asbestos. Hemminki K.25:749-756. and mesothelioma tissues of North American Insulation Workers. Sontag JM. et al. Li X. Exposure of UK Industrial plumbers to asbestos. Checkoway H. Teschke K. schools and buildings. Sporn TA. Alleman T.10:73-89. Anderson HA. Teta MJ. Cantor KP.

Magnani C. Millette. Cutting of Certain-Teed Asbestos Containing Pipe: Work Practice Study. Int Arch Occup Environ Health 1994. vs. Gardner MJ. CIH. and properties of asbestos cement dust. Burdett 5.2:9 14. Dopp E. Page 22 of 39 . Particle and Fibre Toxicology 2005. Dement JM.Textile workers: Loomis D. Gardner MJ. Cutting CertainTeed Asbestos Cement Pipe: Report of Results-MVA7946. Report by G. Raterman. 11th Judicial District..66:7-11 13. Revision #1 4. Occup Environ Med 2007. Helsen J.40:375-379 8. Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers. Follow up study of workers manufacturing chrysotile asbestos cement products. Powell CA. Powell CA.65:164-170.37:33-41 7. Gylseth B.66:535-542. Mortality of asbestos cement workers using almost exclusively chrysotile fibre. A.36:124-126 10. Giaroli C. British J Indust Med 1985. Wolf SH. HSL/2007/11. Mortality of workers in a French asbestos cement factory 1940-82. Mortality of workers employed in two asbestos cement manufacturing plants. Hughes JM. et al. Richardson DB. Occup Environ Med 2009. 2004-51352-L 6.44:161-174 12. Harris County District Court. J Soc Occup Med 1986. ROS-mediated genotoxicity of asbestos-cement in mammalian lung cells in vitro. Alies-Patin AM. Mowe G. et al. Jr.42:219-225 9. No. Asbestos exposures during the cutting and machining of asbestos cement pipe. et al. Wannag A. Affidavit of Susan M. Pannett B. PhD 3. October 2002. Valleron AJ. Deruyttere A. Smith Corporation. in re: John Robinson (Estate of Charles Whitehead. EEH report dated 03/16/1977 and commissioned by the AC Pipe Producers Association. Fiber type and concentration in the lungs of workers in an asbestos cement factory. Investigation of the chrysotile fibers in an asbestos cement sample. Cancer risk after cessation of asbestos exposure: a cohort study of Italian asbestos cement workers. British J Indust Med 1980. British J Indust Med 1983.43:726-732 11. Products Associated with Asbestos Exposure: Cement pipe: 1. Baeten J. Prepared by James R. et al. 2. Nature.O. British J Indust Med 1987. et al.) et al. structure. Materials Analytical Services report. Mortality study of asbestos cement workers. Winter PD. British J Indust Med 1986.

Middleton CG. 10 8. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.. Am Ind Hyg Assoc. Fischbein A. pages 22612-22790. anthophyllite & Actinolite. taping and joint compounds: 1. Ban of consumer patching compounds containing respirable free-form asbestos. Pathology of Malignant Mesothelioma. No. Science 1975. Hillerdal G.54:S9(35). Hodgson JT. Selikoff IJ. Darnton A. Am Ind Hyg Assoc 1979. 19. 14. Hammar MD re Asbestos and Joint Compounds dated 12-22-10. Langer AM. Occupational Safety and Health Administration. Colorado. Drywall construction and asbestos exposure.39:262-275. 2004. New York. Gypsum Association. Affidavit of Samuel P. 12. Occupational exposure to asbestos in the drywall taping process. Consumer Product Safety Commission. 1974 from J. and specifically Table 6 on page 22644. Affidavit of Dr. Sheahan. Iwatsubo Y. Selikoff IJ. Boutin C. NY Acad Med 1975. Evaluation of exposure to asbestos during mixing and sanding of joint compounds. Denver. source 42 FR 63362). Occupational exposure to asbestos. Depart of Labor. Springer: 2006. Exposure to asbestos in the use of consumer spackling.56:506-513. Ann Occup Hyg 2000. Part II. Roggli VL.S. Fischbein SA. Selikoff IJ. Volume 51. 2nd Ed. Ducamp S. Occupational and community asbestos exposure from wallboard finishing compounds.148:133-142. 16 CFR. Risk of pleural mesothelioma: A French population-based case-control study (1998-2002). Gramond C. 18. Asbestos. Pairon JC. Sporn TA. Verma DK. 29 CFR Parts 1910 and 1926. Mesothelioma: cases associated with non-occupational and low dose exposures. Mesothelioma risk from chrysotile. 1973-1974 10.44:565-601. Hammar case report re Jerry Anderson (L09-365) dated 08-19-10 filed in Federal court for Waters & Kraus. Scand J Work Environ Health 1997. 5. Rolland P. April 1980 7. eds. Darnton A. 20. Pathology of Asbestos-Associated Diseases. Epidemiology of Mesothelioma.189:551-553 9. Am J Epidemiol 1998.1304. tremolite. Springer: New York. Nicholson WJ. 13. et al. patching and taping compounds. Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study. Rödelsperger K.23:311-316. Occup Environ Med 1999. asbestosis and cancer: The Helsinki criteria for diagnosis and attribution.Drywall. Rohl AN. 16. Rohl A. Pohlabein H. Langer AM. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results from a German hospital-based case-control study. Federal Register 1986.5 (1-1-97 Ed. Richard Lemen dated April 26. page 3. Galateau-Sallé F.40:402-407 6. Ch 11. Kaiser Gypsum Interoffice Memorandum dated March 1. 3. Nicholson WJ. Page 23 of 39 . Occup Environ Med 2009. 17. Oury TD. 21. Affidavit of Richard Hatfield (undated) re the levels of exposure resulting from the use of joint compounds 4. Final Rules. Rohl AN. Lung Cancer 2006.. Am J Ind Med 2001. et al. 15. et al. Subject: Dust from Joint Compound Job Operations 11. In: Galateau-Sallé F. Hodgson JT. Helsinki Consensus Report. 2006. Jöckel KH. 2.

Leigh. Gaskets: 1.17:190194. 2nd ed. Am Ind Hyg Assoc J 1992. Detection of amphibole asbestos in chrysotile sheet gaskets.11:11131124. Lorimer WV et al. Evaluation of airborne asbestos fiber levels during removal and installation of gaskets and packing. Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability. Mt Sinai J of Med 1976. Murphy RL. Hammar SP (eds. Moore RW. epidemiology.45:229-237. Int J Occup Environ Health 2005. J. Mesothelioma in an individual following exposure to crocidolite-containing gaskets as a teenager.104:576- Friction products/Brakes: 1. Hammar SP. 2000 6. 5.g. Exposure to asbestos from asbestos gaskets. Williams MG.43:207-218. Exposures to asbestos arising from bandsawing gasket material. Appl Occup Page 24 of 39 . Rodelsperger K et al. See discussion by Lemen RA concerning Brake repair and installation workers in Asbestos: Risk assessment. Finkelstein MM. Pleural mesothelioma in a brake mechanic. Asbestos in brakes: exposure and risk of disease. 3. Schosek K. and health effects. Al Bazzaz FJ.46:6971.15:404-408. James Leigh to the US EPA dated 10/1/03 9. Ann Occup Hyg 2008. Am J Indust Med 2004. Fowler DP. Lemen RA. Appl Occup Environ Hyg 2002. Br J Ind Med 1989. Int J Occup Environ Health 2011.11:360-371 (see also Tab 11) 4. Am J Ind Med 1986. Appl Occup Environ Hyg 2000. Poye LW. Cheng RT. WTO document re friction products (e.52:455-461 2. Lynch JL. OSHA 2006. Welch L. Henderson DW. Dodson RF. 3. but not this asbestos exposure: An amicus brief to the Michigan Supreme Court. Billings MA. 5.10:63-72. McKinnery WN. Int J Occup Environ Health 2007. Crossman RN. brake linings). Letter from Dr.53:531-532. 2. 8. McDermott HJ. 10. Levine BW. Dodson RF. Asbestos fibre concentrations in the lungs of brake workers: Another look. Asbestos exposure of brake repair workers in the United States. Appl Occup Environ Hyg 1996. Asbestos exposure causes mesothelioma.13:318327. 6. Dodson RF. European Communities Measures affecting asbestos and asbestos-containing products: report of the panel. Asbestos dust exposure during brake repair. Automotive brake and clutch repair work.. Quantification of fiber releases for various floor tile removal methods. Fiber release during the removal of asbestos-containing gaskets. Am Rev Respir Disease 1971.17:55-62. Huncharek M et al. Lauderdale J. Longo WE et al.) CRC Press/Taylor Francis 2011:172-175. 2. Floor tile installation as a source of asbestos exposure. Burgess WA. 7. World Trade Organization-WT/DS135/R300-304. Egilman DS. (Plaintiff s exhibit not dated) 4.Floor tiles: 1. Hubbard & Longo.

Inhal Toxicol 2006. 3. 13. et al. Slade J. Cancer Res 1995. Am J Ind Med 2004. of Labor/OSHA dated October 24.321:1220-1223. Exposure to asbestos-containing gaskets during AC compressor remanufacturing. 9. Cohort mortality study of pulp and paper mill workers in British Columbia. MAS report dated May 6. 2005. Dept. 1993. 8. New Hampshire. Millette JR. J Toxicol Environ Health 2009. 1979-1999.12:124-156 Pulp and Paper Mills 1.9:1932-1942 2. Greenberg M. Parker FM. 10.18:679-684. Rigler MW. Mortality among pulp and paper workers in Berlin. Occup Med 2003.146:186-194 Page 25 of 39 . MVA0858 report of results concerning Flexitallic gaskets dated April 21. MVA0478 report of results concerning Crane packing materials dated April 12. et al. et al. Eur Respir J 1996. et al. Pleural mesothelioma in a woman whose documented past exposure to asbestos was from smoking asbestos-containing filtered cigarettes. Am J Epidemiol 1997. Dodson RF. Millette JR. 1994. Hilliard AK. Hollins DA.S. The doctors and the dockers. Asbestos-containing sheet gaskets and packing. Thurber WA. McDonald JC. Henneberger PK. Millette JR et al. Talcott JA. MVA6896 report on analysis of materials for asbestos in Cranite gaskets dated January 25. Hammar SP. Letter to U. MVA6896 report on analysis of materials for asbestos in Garlock 7228 gaskets dated January 25. Millette JR.45:573-581 4. Band PR. Sourcebook on Asbestos Diseases. Longo WE et al. N Engl J Med 1989. The epidemiology of mesothelioma in historical context.55:2232-2235. Kantor AF. Kent cigarettes: 1. 2007.53:209-212 3.10-15. Asbestos-associated diseases in a cohort of cigarette-filter workers. The rise and fall in incidence of malignant mesothelioma from a British Naval Dockyard. May 1978. McDonald AD. Jappinen P. Crocidolite asbestos fibers in smoke from original Kent cigarettes. Longshoremen/Dockworkers/Shipbuilding Industry/Shipyard Workers 1. Canada. 7. 2. 14.44:580-587 2. Br J Ind Med 1989. Releasability of asbestos fibers from asbestos-containing gaskets. CIH. Millette JR. 2007. Longo WE. Asbestos exposure from gasket operations. 11. Millette JR.46:658-664 3. Navy Regional Medical Center. Br J Ind Med 1987.6:588-591. A visual historical review of exposure to asbestos at Puget Sound Naval Shipyard (1962-1972). 12. EIA Technical Journal 1995. 15. 2001. Bremerton.Environ Hyg 1991. et al. A mortality study of Finnish pulp and paper workers.

Environ Sci Technol 2004. Inc. Fibrous mineral content of consumer talc-containing products. Roberts S. Lemen R. Vianna NJ. 1979. Talc Bulk Sample Analyses by NIOSH. Electron Microscope Analyses of RT Vanderbilt Talcs collected from Talc Suppliers. Dement JM. Malignant mesothelioma: epidemiologic patterns in New York State. Kleinfeld M. Maslowsky J. October 1976. Bopp RF. Dement JM. Exh 358 6.. NIOSH Health Hazard Evaluation Report No. Pathotox Publishers. Exh 257 12. Abraham JL. Exh 355 5. Donald Miller. Internal Correspondence: Johns-Manville October 11. A-24-A25. Webber JS. Kooyman O. Exh 745 3.T.RT Vanderbilt Talc 1. Exh 381 13. Zaki MH. Dement and Ralph D. Ann Occup Hyg 2002. pages 393-403.April:735-738.16:345-349. Memorandum to J. Rohl AN. Jackson KW. NIOSH re employees of R. Case BW. Mesothelioma among workers in asbestiform fiberbearing talc mines in New York State. Exh 189 7. Exh 436 Page 26 of 39 . Number One Mine and Mill. Thompson concerning Asbestos in Your Future. asbestine 325. In: Dusts and Disease. Nytal 200. Langer AM. Brown DP. Mortality among talc miners and millers in New York State. Zumwalde. Mortality patterns among miners and millers occupationally exposed to asbestiform talc.14:663-667. 1974 re Optical and TEM counting of asbestos minerals in asbestine 3X. M. 1977 re Paper by C. J Occup Med 1974. Inc. NY State J Med 1981. Messite J. Letter to Am Ind Hyg Assoc J June 1982. Dement JM. Arch Environ Health 1967. and Nytal 400 as currently produced by R. NIOSH Technical Report re Occupational Exposure to Talc Containing Asbestos. Summary Report of DRDS Ethical and Legal Investigation dated August 11. Analyses performed by John M. Exh 564 2. 9. Exh 41 11. Director. Brown DP.T. 90-390 and MHETA 86-012 re RT Vanderbilt Company. Exh 822 4. Hull MJ. Reconstruction of a century of airborne asbestos concentrations. et al. Exh 42 10. Volume II.38:707-714. Exh 264 14.46:132-135. Kleinfeld M. Wagoner JK. Messite J. et al.S. Internal Correspondence: Johns-Manville February 18.D. 1988. Mortality experiences among talc workers: a follow-up study. Parekh P. Final report Industrial Hygiene Study of the Gouverneur Talc Company. Vanderbilt Company. Vanderbilt Company. 8.

178:624-629 6. Environmental exposure to asbestos and the exposure-response relationship with mesothelioma. Page 27 of 39 .15:25-38. Darnton A. 3.100:1175-1183. which is outside the acceptable cancer risk ranges of EPA. 2. Pan XL.S. Inc. et al. Occup Environ Med 1995. Mapping the risk of mesothelioma due to neighborhood asbestos exposure. Day HW.52:362-367. 4. Gilham C. EPA Office of Enforcement and Compliance Assurance: A guideline for ship scrappers: Tips for regulatory compliance. et al. 12. Occupational. Luce D. El Bokhary MS. 5. Magnani C. et al. Curr Opin Pul Med 2000. April 20. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. et al.67:417-421. EPA 315. Wang W. Rake C.0002 f/cc translates in the protocol to an increased cancer risk of 1 in 1. Kurumatani N. Environ Health Perspect 2007. EPA Region 9: Response to the November 2005 National Stone. Sand & Gravel Association Report prepared by the R. Rey G. Occup Environ Med 2010. Hodgson J. Environ Research 1997. Mesothelioma incidence and community asbestos exposure. Berry M. Hatch J. Awad Allah HI. et al. Br J Cancer 2009. et al. Am J Respir Crit Care Med 2008. Am J Respir Crit Care Med 2005.6:371-377.000 exposed individuals. Eastern Mediterranean Health Journal 2009. Goldberg S. Kumagai S.172:1019-1025. Summer 2000. Evaluation of EPA s analytical data from the El Dorado Hills Asbestos Evaluation Project.Lee Group. Statement by the EPA concerning each and every exposure. Italy. U. 11. Pleural malignant mesothelioma and non-occupational exposure to asbestos in Casale Monferrato. 2006 (Rejection of Berman-Crump and statement that a concentration of 0.J. Modeling mesothelioma risk associated with environmental asbestos exposure. Environmental asbestos exposure and mesothelioma. Maule MM.83:104-111 9.see pages 12-14 of document) 10. British Journal of Cancer 2000. Magnani C. 8. Cal/EPA and most other state and federal health agencies . Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates. Madkour MT.115:1066-1071 7. Peto J. Multicentric study on malignant pleural mesothelioma and nonoccupational exposure to asbestos. domestic and environmental mesothelioma risks in the British population: a case-control study.Environmental exposure to asbestos and EPA: 1.75:34-40. Orenstein MR. Schenker MB.

Report to Congress on Workers Home Contamination Study Conducted Under the Workers Family Protection Act (29 U. 51 No. DHHS(NIOSH) Publication No. Rolland P. Page 28 of 39 .39:262-275. 95-123.56:506-513 f. Vianna NJ. NIOSH. b. Am J Ind Med 1999. Asbestos content of omentum and mesentery in nonoccupationally exposed individuals. Hammar SP (eds. g. Familial Exposure to Asbestos: Citations and Summary Low-dose exposure: a. et al. h. Iwatsubo Y.148:133-42. et al. Rodelsperger et al. suppl 1:236. Sept. Am J Ind Med 2003.54:S9(35). 22644 g. Hammar SP et al. Darnton A. e. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. 1995.56:506-513 b. Dept of Human and Health Services. e. Malignant mesothelioma in women. Epidemiology. Lancet 1978. Goldberg M. Dodson RA. and Health Effects. Occup Environ Med 1999. Am J Epidemiol 1998. Federal Register 1986/Vol.S. 2nd ed. OSHA asbestos PELs and risk.43:188-195. Dodson RF et al. f.S. Ann Occup Hyg 2000. Hillerdal G. Hodgson JT. Household and Non-occupational Exposure: a. 671a). Toxicol Ind Health 2001. Polan AK. c. Lung Cancer 1997. CRC Press/Taylor & Francis Group 2011:189-192.17:138-143.C.). Non-occupational exposure to asbestos and malignant mesothelioma in females. i. 119/pg. Risk of pleural mesothelioma: A French population-based case-control study (1998-2002). Mesothelioma: cases associated with non-occupational and low dose exposures.1:1061-1063. Occup Environ Med 1999. The health impact of nonoccupational exposure to asbestos: What do we know? European J Cancer Prevention 2009. Dodson RF et al. d.35:281-286. Quantitative analysis of asbestos burden in women with mesothelioma. c.18. Am J Ind Med 2001.Familial. E-mail from Dodson See discussion on Take Home and Community Exposures to Asbestos in Chapter 5 by Lemen RA in: Asbestos: Risk Assessment. Hillerdal G. Tissue burden of asbestos in nonoccupationally exposed individuals from East Texas. Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study. Luce D. Dodson RF et al.44:565-601. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results from a German hospital-based case-control study. d. Mesothelioma: cases associated with non-occupational and low dose exposures. Familial Exposure to Asbestos (List of 50 references) j. U. Lung Cancer 2006.

Pennella A. 16. Mod Pathol 2005:18:446-450. Ultrastructural Pathology 2002. Asroli S. Kane S. Crotty TB. Scattone A. Bharde S. 19. 18. Damiani S. 10. 3. 20. Am J Surg Pathol 2000:24:816-823. Deciduoid mesothelioma: a report of 5 cases and literature review. 15. Okonkwo A. Keeney GL. Virchows Arch 2004:445:206-209. Malignant deciduoid mesothelioma: a diagnostic challenge. Nagy P Szentirmay Z. Nguyen G. Hosone M. Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Musunuri S. Case report: deciduoid peritoneal mesothelioma: a report of the cytological appearances. Deciduoid peritoneal mesothelioma: CT findings with pathologic correlation. Bartels H. Putlaguata L. et al. et al. Orosz Z. Chung DJ. Kang YW. Indian J Pathol Microbiol 2000:43:479-483. Primary epithelial malignant mesothelioma of the pericardium with deciduoid features: cytohistologic and immunohistochemical study. Reis-Filho JS. Asonuma S. 17. Klimstra DS. Banerjee SS. Al-Nafussi A. Epithelial mesothelioma with deciduoid features. Am J Surg Pathol 1994:18:357-363. Monaghan H. et al. Henley JD. Nascimento AG. distinct entity with unusual features. Ogasawara T. Virchows Arch 1999:434:263-266. Harris M. Deciduoid epithelial mesothelioma of the pleura with focal rhabdoid change. et al. A clinicopathologic and flow cytometric study. et al. Ann Diag Pathol 2001:5:168-171. et al. Erlandson RA. Respiration 2000:67:456-458. et al. Am J Surg Pathol 2001:25:547-548. et al. Diag Cytopathol 2002:26:117-122. 13. Malignant peritoneal mesothelioma deciduoid or anaplastic variant? Point to ponder. et al. Am J Surg Pathol 1985. Goubin-Versini I. 9. Am J Surg Pathol 2000:24:1440-1443. Kimura N. et al. Milanezi F. Deciduoid pleural mesothelioma. Diaz L Jr. Chilcote RR. Am J Surg Pathol 1994:18:439-445. Vriend RA. Kim BK. Am J Surg Pathol 2000:24:285-294. Talerman A. Pathol lnterna 2004:54:67-72.Mesothelioma Types: Deciduoid mesothelioma: 1. Montero JR. Deciduoid mesothelioma: a rare. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Page 29 of 39 . et al. Histopathol 2001:39:100-107. Deciduoid mesothelioma in the pelvic cavity. Localized pleural malignant mesothelioma: report of two cases simulating pulmonary carcinoma and review of the literature. Derias N. Shanks JH. 14. Gloeckner-Hofmann K. Loehrer PJ Sr. 12. 4. Deciduoid peritoneal mesothelioma: an unusual phenotype affecting young females. Ulbright TM. Deciduoid pleural mesothelioma affecting a young female without prior asbestos exposure. 5. 21. Kenney A. Epithelial mesothelioma with deciduoid features: report of four cases. Arch Pathol Lab Med 2005:129:403-6. Myers JL. 8. Serio G. 6. van der Walt JD. Deciduoid mesothelioma of the pleura after radiation therapy for Hodgkin s disease presenting as a mediastinal mass.26:355-363. Katzenstein AL.12:57-61 11. Histopathol 2002:40:348-352. Granulocyte-colony stimulating factor and interleukin 6-producing diffuse deciduoid peritoneal mesothelioma. de Chaisemartin C. Ordonez NG. Malignant deciduoid mesothelioma of the pleura: report of two cases with long survival. Abdom Imaging 2003:28:614-616. Mourra N. Pope LZB. et al. Katayama H. Cytopathology 2001. Fletcher CDM. et al. Maeda S. Desai S. Localized malignant mesothelioma. Piaz GD. 7. Gillespie FR. Shia J. Zhu X.9:73-80 2.

Corson JM. Churg AM. This entity is discussed in Dail & Hammar s Pulmonary Pathology. Roggli V. Allen TC. Ordonez NG. Ectopic decidua mimicking metastatic lesions report of three cases and review of the literature. et al. Grapsa D. Chapter 43. Am J Clin Pathol 2005:123:724-737. Am J Surg Pathol. Localized Malignant Mesothelioma. Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Baker PM. page 649 Page 30 of 39 . Grimes MM. Clement PB.22. 3rd Edition. 24. Hammar SP. Travis WD. Kondi-Pafiti A. Eur J Gynaec Oncol 2005:26:459-461. Kontogianni-Katsarau K. Wick MR. 2005. 23. Volume II.29:866-873. Gibbs AR. Cagle PT. Young RH. Colby TV.

Localized primary tumors of the pleura: an analysis of 40 cases. Takeda S.. Tunzozgur B. et al. 3. et al. Metastatic mesothelioma . Cancer 1979. 8. localized mass 3. 10. Tazelaar H. Takahashi H. 11. immunohistochemical.64:881885. Maehara S. 78-year-old man with 2 x 5 cm nodule extrapleural. epithelial. RX resection. et al. et al. Localized malignant mesothelioma: a case report. Kishimoto T. 54-year-old man with history of asbestos exposure for three years. Lab Invest 1992. Hammar SP. Churg AM. Ann Thorac Cardiovasc Surg 2007. (eds. Localized pleural malignant mesothelioma. Allen TC. Fraire AE (Ed).66:115A. A case of benign localized mesothelioma with occupational history of asbestos exposure. Localized malignant mesothelioma: a clinicopathologic and flow cytometric study. Kamei T. Crotty TB. and flow cytometric analysis of three cases. Localized pleural malignant mesothelioma. Tomashefski JF Jr. 5. Kato H. et al. Localized malignant epithelioid and biphasic mesothelioma of the pleura: clinicopathologic. et al.18:357-363 9. Internullo E. RX surgery.Localized malignant mesothelioma: 1. 56-year old Japanese male with no hisotyr of asbestos exposure. 2. Katzenstein AL. 6. Chapter 43 Henderson DW.51:654-660.unusual locations: Draft of Table 43-24 from Dail & Hammar s Pulmonary Pathology. Localized malignant pleural mesothelioma: report of two cases. Localized malignant mesothelioma. Neoplasms of the Pleura.4:1038-1040. Harada M. 3rd edition. Tiseo M.51:812-815. 5 cm left posterior mass.1 cm. Pathol Int 2003. ? age. recurrence yes. Am J Surg Pathol 2005. 61-year-old male with no history of cigarette smoking or asbestos exposure. Localized malignant mesothelioma of the pleura. Okamura H. ? sex. Zolliker AS. sarcomatoid localized malignant mesothelioma. 3rd Ed. Dodson RF. Am Surg 1998.29:866-873. (US-Canadian Mesothelioma Panel paper). Ojeda HF et al. 66-year-old with history of asbestos exposure. poorly-differentiated malignant mesothelioma. McCaughey WTE. Springer 2008. 7. Am J Surg Pathol 1994. history of asbestos exposure.29:16031607. Localized mass. et al. Hirano H. J Thorac Oncol 2009.13:262-266. Dalton WT. biphasic meso 4. Cagle PT. Cagle PT. recurrence. Farver CF. Localized malignant mesothelioma of the pleura. recurrence 5 months following surgery. Tomashefski JF Jr. Sari I. Mitsuno A.5 cm. Tanzi S. Erkilic S. Article in Japanese: Nihon Kyobu Shikkan Gakkai Zasshi 1991. Pathol Int 2001.2 x 3. 4. Katzenstein A-L. See pages 660-661 of Volume II. ? recurrence. et al.) Springer 2008 Page 31 of 39 . Myers J. 5-cm RUL lung mass. RX surgery.44:1465-1475 This entity is also discussed in: Dail and Hammar s Pulmonary Pathology. Sawabata Y. Pathol Int 2001. metastases yes. Klebe S.53:616-621. Myers JL.

Peritoneal mesothelioma: 1. 3 (23%) had counts over 1 million fibers per gram of wet weight. Krausz T. Husain AN. Chest 2000. Huang J. O Sullivan M. 13 women had a history of domestic bystander exposure to asbestos. and fibres. Deraco M. Toxicology and Industrial Health 2002. 5 peritoneal mesotheliomas with high concentrations of asbestos fibers/bodies identified in 3 cases and significantly lower concentrations in 2 cases. Modern Pathol 2005. Clement PB. Guidelines for the pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. arsenic. 14. and non-neoplastic lesions.18:S113-S129. 13. A 17-year-old boy whose lung tissue contained 316. 671a) in 1995. Asbestos exposure and ovarian fiber burden. 6. Holiday DB. Westhoff C. O Sullivan MF. Hammar. Arch Environ Health 1979. 11. Malignant peritoneal mesothelioma: quantitative analysis of asbestos burden. 3.29:435-439. A mechanism for relocation is via the lymphatic circulation. Mohr U. Ordonez NG. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats.21:321-336. Asbestos content of omentum and mesentery in nonoccupationally exposed individuals. dusts. 7. 2.59:823-827. This study suggests their presence can be predicted based on concentrations and characteristics of fiber burdens in lung tissue. This study shows that asbestos fibers also reach the mesentery and omentum in the peritoneal area. Analysis of asbestos fiber burden in lung tissue from mesothelioma patients. Epidemiology of peritoneal mesothelioma: a review. Pathology International 2009. Asbestos in the lungs of persons exposed in the USA. Corn CJ. Nolan RP. See Table 2 re Health Effects of Take-Home Asbestos Exposure (Cohort Studies).17:1-6. Findings show that peritoneal mesotheliomas occur at a variety of concentrations of asbestos in lung tissue. Asbestos fibers reach areas in the peritoneal cavity where some mesotheliomas develop. A review of human carcinogens Part C: metals. et al. 9. 6/17 women had detectable asbestos in their ovaries (35%) with 1 (6%) having a count over 1 million fibers/gram wet weight.23%). Gerber S. Malignant peritoneal mesothelioma in a 17-year-old boy with evidence of previous exposure to chrysotile and tremolite asbestos. www. Bosia. et al. Asbestos in extrapulmonary sites omentum and mesentery.000 fibers Page 32 of 39 .44:55-58. 5.53:168-180. Nagai Y. 12. Dodson RF.18:985-990. Rittinghausen S.10:453-454. Langer AM.98:268-272. Colby TV. A special report: policy. Andrion A. Paoletti L. 15.133:1317-1331.com/oncology. Bartlett D. mesothelial lesions. et al.117:486-493. Gardner MJ. Baratti D. Selected miscellaneous ovarian lesions: small cell carcinomas. 9/13 women exposed to asbestos had asbestos in their ovarian tissue (69. J Surg Oncol 2008. The Lancet 2009.thelancet. Gordon RE. Mesothelioma and exposure to mixtures of chrysotile and amphibole asbestos. Ernst H. Am J Ind Med 1996. IARC. Dodson RF. Acheson ED. Exp Tox Pathol 1992.34:240-242. Ann Oncol 2007. 10. mesenchymal and mixed neoplasms.25:617-622. Monaldi Arch Chest Dis 1998. Arch Pathol Lab Med 2009. Human Pathology 1994. Dodson RF. Kusamura S. NIOSH Report to Congress on Workers Home Contamination Study Conducted Under the Workers Family Protection Act (29 USC. Heller DS. Kishimoto T. et al. Boffetta P. Ultrastructural Pathology 1997. 8. Kurimoto R. Asbestos fibers in occupationally exposed individuals relocate from the lung to extrapulmonary sites. Muhle H. 4. SP. Consensus Statement on Peritoneal Mesothelioma. et al.

Western Australia. Kohyama. Schalet N. 2 peritoneal mesotheliomas. 32 cases of peritoneal mesothelioma. 25. 20. Three peritoneal mesotheliomas and one peritoneal/pleural mesothelioma in patients employed in an asbestos textile factory. Berry G. The length of the chrysotile fibers ranged from 1. 5% of the chrysotile fibers were >5 microns long and 30% of the tremolite fibers were 5 microns long. Asbestos fiber content of lungs with mesothelioma in Osaka. Musk AB et al. Symons MJ and Shy CM. Reid A. 18.61:e14. Yasui Y. Mann RH.000 fibers of tremolite asbestos per gram of dry lung tissue. Mobiglia A. et al. 17. et al. 27 peritoneal mesotheliomas. Godwin MC. Sera Y. Mortality of former crocidolite (blue asbestos) miners and millers at Wittenoom.643:347-367. Methodology of industrial health studies: The cohort approach with special reference to an asbestos company. Harris RL Jr. Four peritoneal mesotheliomas that occurred among railroad workers in Italy where chrysotile was the type of asbestos prevalently used. 21. Conston A.of chrysotile asbestos per gram of dry lung tissue and 194. O Donnell WM. de Klerk NH. 27. Mirabelli D. Asbestos content of lung tissue in patients with malignant peritoneal mesothelioma: a study of 40 cases. Annals of New York Academy of Science 1991. Asbestos body and fiber concentrations of pathological autopsy tissues of patients with malignant peritoneal mesothelioma. Cancer: 1966. American Journal of Industrial Medicine 1983. Suzuki Y. Hammar SP. Grosh JL. 24. One peritoneal mesothelioma occurring in a chrysotile textile production operation worker. 33 peritoneal mesotheliomas. Asbestos: an extrinsic factor in pathogenesis of bronchogenic carcinoma and mesothelioma. Thompson H. Occup Environ Med 2008. Archives of Environmental Health 1963.18(Suppl 1):235-236.19:1143-1148. Takizawa V. 16. Occup Environ Med 2007.5 to 20 microns and had a mean of 12 microns. 19.. Part II: Mortality. Twenty-one peritoneal mesotheliomas in individuals who worked in an asbestos mill where chrysotile was the only fiber used in the textile division of the mill. Mesothelioma of the pleura and peritoneum following exposure to asbestos in the London area.64:641-646.6:210226). 90:438-443. Chrysotile Page 33 of 39 . Yokoyama K. Sasaki M.65:815-819. Occup Environ Med 2004. Mesothelioma following exposure to asbestos: a review of 72 cases. Maltoni C. Br J Ind Med 1965. Four peritoneal mesotheliomas occurring in workers in the manufacturing of brake linings. Excess of mesotheliomas after exposure to chrysotile in Balangero. Saitoh K. Newhouse ML. Borow M.5 to 15 microms and had a 5 micron average length. Asbestos and mesothelioma. Abstract 923. The tremolite fibers ranged from 0. Exposures and mortality among chrysotile asbestos workers. Two peritoneal mesotheliomas. Oury TD. Mancuso TF et al. One peritoneal mesothelioma occurring in a 54-year-old design engineer whose lung tissue contained only chrysotile asbestos. Jagatic C. Pinto C. Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom. 23. Lung Cancer 1997.204:1009. Hachiya N. 22. one occurring in a 62-year-old male with probable asbestos exposure and a 42-year-old female nurse with unlikely known exposure to asbestos. A case of peritoneal mesothelioma in a man who had worked as a young adult three years weaving brake lining made from chrysotile asbestos. Mesotheliomas due to asbestos used in railroads in Italy. 26.50:325-332. Muto H.4:421-433. Dement JM. IARC Science Publication 1989. Roggli VL. Italy. Chest 1973. Morinaga K. JAMA 1968.22:261-269. 28. Livornese L. Hara I. Japan: A preliminary report. Bulletin of Environmental Contamination and Toxicology 1993.

2nd ed.62:665-669. 20 peritoneal mesotheliomas (18 in workers and 2 in residents). Asbestos and peritoneal mesothelioma among college-educated men. A case of occupational peritoneal mesothelioma from exposure to tremolite-free chrysotile in Quebec. Menendez LM. Ambrosini G. Lancet 1978. 11 females). occupational and geographical associations. 32. 33. Lewinsohm HC. 30. Teta BE. Int J Occup Environ Health 2005.fibers were identified in the lung tissue of each case with lower concentrations in the nurse. Vianna NJ. 34. 9 peritoneal mesotheliomas. Occup Environ Med 2005. Polan AK. 29. Journal of Occupational Medicine 1983. Hammar SP (eds). Mesothelioma in Connecticut (1955-1977). 1 milliner.25:749-756. Mortality experience of amosite asbestos factory worker: dose-response relationships 5 to 40 years after onset of short-term work exposure. Epidemiology and Health Effects. Reid A. CRC Press/Taylor & Francis Group 2011. 31. Non-occupational exposure to asbestos and malignant mesothelioma in females. Gelb SK. Dodson RF. Vidone RA. 1 paraoccupational exposure). de Klerk N. Page 34 of 39 . 22 out of 24 men (92%) with peritoneal mesothelioma reported potential exposure to asbestos. Selikoff IJ. Miegs JW. Identified 29 cases of peritoneal mesothelioma (18 males. Am J Ind Med 1986. Egilman D. Welch LS et al.10:479-514.6 for asbestos exposure among this group of primary peritoneal mesotheliomas with relatively slight asbestos exposure. et al. Mowad LZ. The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. Odds ratio 6. 20 confirmed deaths from peritoneal mesothelioma in women residing in NY State between 1966 and 1977 (asbestos exposure in 2 textile workers.1:1061-1063. Am J Ind Med 2010.11:254-258. Canada: A black swan case. 40 primary peritoneal mesotheliomas from a single institution. This entity is also discussed in Asbestos: Risk Assessment. Seldman H. Flanner JT.

Robb JA. et al. Shah IA. Pseudomesotheliomatous lung cancer: a rare asbestosrelated malignancy readily separable from epithelial pleural mesothelioma. Simonsen J. The Netherlands Journal of Medicine 2001. Pseudomesotheliomatous carcinoma of the lung. Arch Pathol Lab Med 2001. Adenocarcinoma simulating mesothelioma: A clinicopathologic and immunohistochemical study of 29 cases. 3rd edition.65:159-167. Yokoo H. Lab Invest 1993. 2002 18. Hartmann C-A. Falconieri G. 7. Pseudomesotheliomatous adenocarcinoma: A re-appraisal. In Dail and Hammar s Pulmonary Pathology.3:148-159.22:239-242. Travis W. CRC Page 35 of 39 . Corrin B.Pseudomesotheliomatous Adenocarcinoma: 1. Acta Pathol Jpn 1983. Bussani R.191:1147-1151. Collins WM. 13. Blasi A. Mesothelioma-like tumors of the pleura: a review of 72 autopsy cases. van Hengel P. Klebe S. Springer 2008:670-672. et al. 4. Hammar SP. Dodson RF.120:331-347. 6. 10. 12.125:1598-1600.33:415-423. Pseudomesotheliomatous carcinoma of the lung with histochemical and immunohistochemical study. Acta Cytologica 1978. Henderson DW. Tsung SH. Schutze H. Ann Diagn Pathol 1998. 7:49-51. Am J Clin Path 1976. Fleming M. Southern Medical Journal 1980. Gracey DR. Pseudomesotheliomatous carcinoma involving pleura and peritoneum: a clinicopathologic and immunohistochemical study of three cases. Pulmonary adenocarcinoma simulating malignant mesothelioma. Sem Diag Pathol 1992.68:17471753.. Dessy E. Vatsia SK. 3. 8. Histopathology 2003. Pathol Res Pract 1995. Harwood TR. 5. Ann Diag Pathol 1998. Hochholzer L. 11. Tang P. Pseudomesotheliomatous carcinoma of the lung. 14. Saito K. Ultrastruct Pathol 1996. 16. Dodson RF. Tseng CH.29:314-322. Small cell carcinoma of lung simulating mesothelioma. Dewar A. Pietra GG. The pathologic features of asbestos-induced disease. Pseudomesotheliomatous carcinoma of the lung: an immunohistochemical and ultrastructural study of three cases. Ohno T. 17. Broghamer WL Jr. and Health Effects. Gibbs AR. Koss MN. Moran C. Kumnet T. Kahn E. Travis W. Hammar SP (Eds). In Asbestos: Risk Assessment. The pleural form of primary cancer of the lung. Koss M. J Cancer Res Clin Oncol 1994. Zanconati F. 2nd ed. Cardiff. Atypical carcinoid presenting as mesothelioma.43:444-452 This entity is also discussed in: Hammar SP. Adenocarcinoma simulating mesothelioma. Diseases of Chest 1956.58:185-190. Yooko H. Neoplasms of the pleura. Am J Forensic Med Pathol 1986. 9:117-132. 9. Hochholzer. Nishimoto Y. Pseudomesotheliomatous carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group. Mojsejenko IK.73:655-657.(ed). Przygodzki RM.20:327-329. van Geffen F. 2. A variant of peripheral lung cancer. Babolini G. Attanoos RL. et al. Teichberg S. The cyto-histopathology of a pseudomesotheliomatous carcinoma of the lung.68:134A. Salvatore JR. Pseudomesotheliomatous carcinoma of the lung with asbestos exposure. Hammar SP. Hammar SP. Sherrod A. Epidemiology.2:93-102. 15. Tomashefski JF Jr. Lin JI. Cancer 1991. Pseudomesotheliomatous carcinoma of the lung: a report of three unusual cases with review of the literature.

We have full article. Chen JL. Horta AL. 5. Diagn Cytopathol 1996. J Surg Oncol 2006. Simi U. We have full article. 10. Garcia de Jalon A. Modern Pathology 2010. We have full article. 3. Dimitrov NV. Schreiber K. O Sullivan MF.56:84-88. 15. Bruce JR. Int Urol Nephrol 2003. Liguori G. Cancer 1998. Illei PB. Brooks DR. Pinelli M. Malignant mesothelioma of the tunica vaginalis: a clinicopathologic analysis of 11 cases with review of the literature. Hsu YH.13:211-214. Concomitant malignant mesothelioma of the pleura. Candura SM. Al-Qahtani M. Young RH. 2. Malignant mesothelioma of the tunica vaginalis testis. Fligiel Z. van Dalen KC. 13. Ruitenberg HM. Gibbs AR.17. Canto A. We have full article. 6. et al.94:162-164. Malignant mesothelioma of the tunica vaginalis testis: a case report and review of the literature. 8. Asian J Androl 2007. van Dalen T. Mesothelioma of the tunica vaginalis testis: 1. 17. 7.25:77-81. Schure PJ. We have full article. Asbestos content of omentum and mesentery in nonoccupationally exposed individuals.Press/Taylor & Francis 2011:419-431. Primary malignant gonadal mesotheliomas and asbestos. Faccioli F. et al.14:3514-3517. 16. Sforza V.49:119-127. Kaohsiung J. Murai Y. Onerheim R. Journal of Clinical Oncology 1984. Mesothelioma of the tunica vaginalis testis: a rare malignancy mimicking more common inguino-scrotal masses. Cohen S. Kaneko M. Malignant mesothelioma of the tunica vaginalis propria testis in a patient with asbestos exposure: a case report. and tunica vaginalis testis.28:1365-1368.83:2437-2446. Trombetta C. Malignant mesothelioma of the tunica vaginalis. Histopathology 2000. Riedl CR. Page 36 of 39 . Japko L. Jones MA. 14. Brimo F. Cancer 1976. Mesothelioma of the tunica vaginalis: a series of eight cases with uncertain malignant potential.23:1165-1172.14:243-248. We have full article.19:815-825. Malignant mesothelioma in Japan: analysis of registered autopsy cases. Med Sci 2009. Epstein JI. Attanoos RL. et al. Inguinal recurrence of malignant mesothelioma of the tunica vaginalis: one case report with delayed recurrence and review of the literature. Can J Urol 2007. Malignant mesothelioma of the tunica vaginalis testis: report of first case with preoperative diagnosis. 11.37:1478-1484. Scully RE.2:447-451. Amatu A. Arch Environ Health 2001. Gil P. et al. Rahimi S. Azua-Romeo J. peritoneum. et al. Garaffa G. Dawood S. 4. Dodson RF. Malignant mesothelioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters. Am J Surg Pathol 1995. Ascoli V. Cancer 1982. Anticancer Res 2008. et al. 9. Toxicology and Industrial Health 2002. 12.35:59-62. We have full article. Int J Surg Pathol 2005. We have full article. Morris B. Pflüger H. We have full article.9:859-860. Gorini G.37:150-159. Malignant mesothelioma of the tunica vaginalis: report of a case without risk factors and review of the literature. Antman K. et al. Malignant mesothelioma of the tunica vaginalis testis in a petrochemical worker exposed to asbestos. Plas E. Mesothelioma of the tunica vaginalis testis: report of 2 cases with asbestos occupational exposure.

JL. We also find evidence of a causal relationship or lack thereof between the following cancers: Cancer: Conclusion: Pseudomesotheliomatous Lung CA Sufficient. but insufficient Esophageal Inadequate Laryngeal Sufficient Pharyngeal Suggestive of. The committee found a causal association or lack thereof between asbestos as listed below: Cancer: Conclusion: Colorectal Suggestive of. CRC Press/Taylor & Francis Group 2011. Vignaud JM. Tumors of the Serosal Membranes. Epidemiology and Health Effects. Page 37 of 39 .). et al. 2006. This book discusses pharyngeal cancer. Institute of Medicine of the National Academies. National Academy of Sciences. Am J Surg Pathol 2001. DWH. depending upon individual case data Lymphoma Insufficient Autoimmune Disease Likely in many cases From Chapter 8: Asbestos and Other Cancers. Am J Surg Pathol 2004. RAL) agree with the above findings by the US Institute of Medicine Committee.28:534-540. Galateau-Sallé F. depending upon individual case data Kidney/Renal Possible Ovarian Sufficient.Well-differentiated papillary mesothelioma: 1.25:1304-1309. Sporn TA. Asbestos: Selected Cancers Asbestos: Selected cancers. Dodson RF. Butnor KJ. 3. In: Asbestos: Risk Assessment. esophageal cancer. Hammar SP. Hammar SP (eds. and colorectal cancer. Gibbs A. but insufficient Stomach (GI) Suggestive of. Burke L. Well-differentiated papillary mesothelioma. stomach cancer. laryngeal cancer. See pages 33 (Figure 4-16) and page 50 (Figure 455). Roggli VL. 2nd Ed. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. 2. but insufficient We (SPH.

Chapter 27. 2. Respiration 2002. Animal Studies: 1.29:252-269. 3.364:1157-1166 Page 38 of 39 . Exp Toxicol Pathol 1992. Mitchev K.65:2602-2609 2. Illei PB.63:71-75 Black spots in pleura: 1. Mesothelioma in pet dogs associated with exposure of their owners to asbestos. Dodson et al. Lancet 2004. Rusch V. Br J Cancer 1974.69:261-267 3. Rittinghausen S et al. 4. Arch Env Occup Health 2008. Environmental Health 2008.7:4 See also page 989 in Dail and Hammar s Pulmonary Pathology. Glickman LT et al. et al. et al.32:305-313. Translocation of inhaled asbestos fibers from the lung to other tissues. Kohyama N. 2. et al. Orally ingested chrysotile asbestos affects rat lungs and pleura. Evidence against a role for SV40 infection in human mesotheliomas and high risk false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. The effects of the inhalation of asbestos in rats. Manfredi JJ. Am J Respir Crit Care Med 1996. Suzuki Y.26:1198-1206 4. Am J Surg Pathol 2002. Dong J. 3rd Edition. et al. Muller K-M. Am J Ind Med 1996. Volume I SV40 virus: 1. Review: Translocation pathways for inhaled asbestos fibers. Cancer Res 2005. Black spots concentrate oncogenic asbestos fibers in the parietal pleura.44:55-58. Environ Res 1983. Hasanoglu HC et al.19:701-704. Boutin C. Am J Ind Med 1991.153:444-449 2. Wen-jun L.29:435439. Heller DS et al.Translocation: 1. Asbestos in extrapulmonary sites: omentum and mesentery. Asbestos exposure and ovarian fiber burden. Wagner JC et al. Lopez-Rios F. Ladanyl M. et al.117:486-493. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibers in rats. Black spots and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Evidence against a role for SV40 in human mesothelioma. 3. Miserocchi G. Chest 2000. Black spots of the parietal pleura: Morphology and formal pathogenesis.

Page 39 of 39 .Radiation-induced mesothelioma: Articles (list of) and Table prepared by Hammar SP.